PubRank

Philip J Norris

Author PubWeight™ 93.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009 4.98
2 CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 2010 3.32
3 Transfusion-related acute lung injury: incidence and risk factors. Blood 2011 3.12
4 Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Sci Transl Med 2011 3.08
5 Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol 2008 2.90
6 Virus and antibody dynamics in acute west nile virus infection. J Infect Dis 2008 2.84
7 The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009 2.56
8 Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol 2010 2.39
9 Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol 2004 2.21
10 Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 2009 2.18
11 Kinetics of early T cell receptor signaling regulate the pathway of lytic granule delivery to the secretory domain. Immunity 2009 1.98
12 The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS 2011 1.94
13 Influenza viremia and the potential for blood-borne transmission. Transfusion 2007 1.69
14 Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 2011 1.62
15 Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals. AIDS 2010 1.57
16 HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 2010 1.57
17 In vitro measures of membrane changes reveal differences between red blood cells stored in saline-adenine-glucose-mannitol and AS-1 additive solutions: a paired study. Transfusion 2013 1.47
18 Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study. AIDS 2013 1.43
19 A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 2011 1.43
20 Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr 2012 1.37
21 Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One 2011 1.32
22 West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion 2014 1.30
23 Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J Acquir Immune Defic Syndr 2007 1.27
24 IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog 2012 1.27
25 Protein kinase C theta regulates stability of the peripheral adhesion ring junction and contributes to the sensitivity of target cell lysis by CTL. J Immunol 2008 1.24
26 Loss of T cell responses following long-term cryopreservation. J Immunol Methods 2007 1.23
27 Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation. J Clin Microbiol 2012 1.18
28 Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. AIDS 2008 1.14
29 Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors. J Infect Dis 2012 1.14
30 Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med 2014 1.11
31 The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. AIDS Res Hum Retroviruses 2006 1.11
32 Labeling antigen-specific CD4(+) T cells with class II MHC oligomers. J Immunol Methods 2002 1.11
33 Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. J Immunol 2004 1.10
34 A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. Proc Natl Acad Sci U S A 2004 1.09
35 Comprehensive analysis of west nile virus-specific T cell responses in humans. J Infect Dis 2008 1.09
36 The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells. Cytometry A 2009 1.09
37 Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J Infect Dis 2008 1.08
38 Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010 1.04
39 Properties of stored red blood cells: understanding immune and vascular reactivity. Transfusion 2011 1.02
40 Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis 2012 1.01
41 Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma. Clin Vaccine Immunol 2010 0.99
42 Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin Hematol 2007 0.98
43 Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 2013 0.98
44 Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion 2010 0.98
45 Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. PLoS One 2011 0.98
46 Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development. Cytokine Growth Factor Rev 2012 0.94
47 Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. Blood 2011 0.91
48 IL-1Β enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease. PLoS One 2013 0.89
49 Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion 2011 0.89
50 The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion 2010 0.89
51 A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties. Eur J Immunol 2010 0.89
52 Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants. Blood 2013 0.88
53 Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors. AIDS Res Hum Retroviruses 2013 0.87
54 Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Res 2013 0.86
55 HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients. AIDS 2014 0.86
56 Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. AIDS Res Hum Retroviruses 2014 0.85
57 Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion 2010 0.84
58 The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry. J Am Soc Mass Spectrom 2006 0.84
59 Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion 2009 0.82
60 HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection. J Clin Microbiol 2009 0.82
61 Identifying the early post-HIV antibody seroconversion period. J Infect Dis 2011 0.82
62 Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection. J Gen Virol 2012 0.81
63 Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion 2012 0.80
64 Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in naive and previously vaccinated blood and plasma donors. J Infect Dis 2013 0.80
65 Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion 2013 0.79
66 Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy. AIDS Res Hum Retroviruses 2014 0.78
67 Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice. Transfusion 2013 0.78
68 Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response. Transfusion 2013 0.78
69 Elevated caspase-3 expression and T-cell activation in elite suppressors. J Acquir Immune Defic Syndr 2010 0.76
70 Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapy. HIV Clin Trials 2015 0.76
71 High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy. Medicine (Baltimore) 2016 0.75
72 CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis. PLoS One 2013 0.75
73 [West Nile virus - I. conquest of the West]. Med Sci (Paris) 2011 0.75
74 [West Nile virus. II. Immunopathophysiology in humans]. Med Sci (Paris) 2011 0.75
75 All plasma products are not created equal: Characterizing differences between plasma products. J Trauma Acute Care Surg 2015 0.75